Human Organoids Market worth $0.90 billion by 2031
The report "Human Organoids Market by Offering (Models, Service), Type (Liver, Kidney, Heart), Culture Type (ECM, Suspension), Source (ASCs, ESCs), Disease Area (Oncology, GI, Neurology), Application (Screening, Toxicity, Efficacy), End User - Global Forecast to 2031" is projected to reach USD 0.90 billion by 2031 from USD 0.29 billion in 2026, at a CAGR of 25.6%.
Browse 531 market data Tables and 54 Figures spread through 405 Pages and in-depth TOC on "Human Organoids Market by Offering (Models, Service), Type (Liver, Kidney, Heart), Culture Type (ECM, Suspension), Source (ASCs, ESCs), Disease Area (Oncology, GI, Neurology), Application (Screening, Toxicity, Efficacy), End User - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/human-liver-model-market-171046468.html
The global human organoids market is expected to expand during the forecast period, supported by demand for finished organoid models and specialized model development and testing services.
Demand for human-relevant drug screening and patient-derived disease models is supporting market adoption. The FDA’s April 2025 roadmap encourages evaluation of non-animal methods, including organoid toxicity testing. The study covers medical and pharmaceutical applications. Separately sold reagents, media, consumables, and instruments, as well as cosmetic, veterinary, food, agricultural, and environmental uses, are excluded.
Ready-to-use and customizable organoid models support access to human-relevant research systems.
Based on offerings, the human organoids market is segmented into organoid models and services. The models segment includes ready-to-use and customizable organoids supplied as finished products. Services comprise model development and organoid model-based testing. Purchasing models lets researchers run studies in their own labs, while outsourcing provides access to specialist development and screening capabilities. Molecular Devices (US), a Danaher company, supplies assay-ready organoids and custom expansion services. HUB Organoids (Netherlands), part of Merck KGaA (Germany), offers custom model development and drug screening.
Kidney organoid models expand tools for renal disease research and therapeutic evaluation.
The human organoid models market covers liver, intestinal & colorectal, kidney, pancreatic, lung, heart, and other models, including brain, retinal, breast, and skin organoids. Kidney organoids let researchers study renal tissue development and disease mechanisms in human-derived systems. Evotec (Germany) offers iPSC-derived kidney organoids and assay systems within its renal research capabilities. Its 3D model platform includes kidney organoids for studying polycystic kidney disease.
Research infrastructure and standardization initiatives support human organoid adoption in North America.
The regional scope comprises North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. North America benefits from biomedical research infrastructure, access to characterized models, and initiatives supporting human-relevant testing methods. The NIH Standardized Organoid Modeling Center aims to improve model reproducibility, scalability, and accessibility for medical research. Its initial focus includes liver, lung, heart, and intestinal models. The Human Cancer Models Initiative also provides patient-derived models and associated clinical and molecular data. These resources support model evaluation and experimental design. Demand for finished models and outsourced testing will depend on validated performance and adoption within pharmaceutical and research workflows.
Companies with relevant organoid capabilities include Merck KGaA (Germany), Danaher Corporation (US), Samsung Biologics (South Korea), WuXi AppTec (China), and Evotec (Germany). Merck’s HUB Organoids and Danaher’s Molecular Devices address model development, screening, or organoid supply. Samsung Biologics and WuXi AppTec provide organoid-based oncology research capabilities, while Evotec offers kidney organoid expertise. Competitive assessment focuses on finished human organoid models and related development and testing services within the study scope.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Human Organoids Market
- What will your New Revenue Sources be
- Who will be your Top Customer; what will make them switch
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
